Oramed Pharmaceuticals Income Statement (2011-2026) | ORMP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Aug2019	Nov2019	Aug2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.68M	0.67M	2.70M	0.67M	0.67M	0.68M	0.90M	0.67M	0.67M							2.00M
Cost of Revenue (Quarter)				0.59M	0.38M	0.46M		0.18M	0.19M	0.66M						1.99M
Gross Profit (Quarter)	0.68M			0.08M	0.29M	0.22M		0.48M	0.48M	-0.66M						0.01M
Operating items
Research & Development (Quarter)	2.20M	2.02M	20.99M	5.84M	9.18M	5.35M	9.04M	4.43M	1.82M	0.96M	1.77M	1.18M	1.44M	2.24M	1.46M	2.21M	1.03M	1.15M	1.99M	1.59M
Selling, General & Administrative (Quarter)	0.83M	1.08M		5.49M	2.53M	3.06M	2.73M	1.26M	2.45M	2.60M	2.11M	1.78M	1.69M	0.85M	2.13M	2.31M	1.46M	1.27M	3.68M	2.06M
Operating Expenses (Quarter)	3.03M	3.10M	20.99M	11.33M	11.71M	8.41M	11.76M	5.69M	4.27M	3.56M	3.88M	2.96M	3.13M	3.09M	3.60M	4.51M	2.49M	2.43M	5.67M	3.66M
Operating Income (Quarter)	9.33M	-2.43M	-24.22M	-11.25M	-11.42M	-8.19M	-12.33M	-5.21M	-3.79M	-2.89M	12.96M	-2.96M	-3.13M	-3.09M	5.84M	-4.50M	-2.49M	-2.43M	25.23M	-3.66M
EBIT (Quarter)																				-3.66M
Non-operating items
Interest & Investment Income (Quarter)																0.65M				0.28M
Other Non Operating Income (Quarter)																				-0.10M
Non Operating Income (Quarter)																				-0.10M
Net income details
EBT (Quarter)																				49.44M
Tax Provisions (Quarter)																				11.13M
Profit After Tax (Quarter)																				38.31M
Income from Non-Controlling Interests (Quarter)			-0.75M	-0.28M	-0.53M	-0.19M	-0.59M	-0.22M	-0.12M	-0.06M	0.83M	-0.00M	-0.01M	-0.02M	-0.01M		-0.03M	-0.01M
Income from Continuing Operations (Quarter)																				38.31M
Consolidated Net Income (Quarter)																				38.31M
Income towards Parent Company (Quarter)																				38.31M
Net Income towards Common Stockholders (Quarter)																				38.31M
Additional items
EPS (Basic) (Quarter)																				0.94
EPS (Weighted Average and Diluted) (Quarter)																				0.91
Shares Outstanding (Weighted Average) (Quarter)																				40.77M
Shares Outstanding (Diluted Average) (Quarter)																				41.97M
EBITDA (Quarter)																				-3.66M
Interest Expenses (Quarter)	0.44M	0.02M								0.83M	1.21M	0.59M	0.26M
Tax Rate (Quarter)																				22.51%

Research Tools

Developers

Oramed Pharmaceuticals Income Statement (2011-2026) | ORMP

Research Tools

Developers

Oramed Pharmaceuticals Income Statement (2011-2026) | ORMP

Create an account

Sign In

Reset Password